{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:32:46Z","timestamp":1791574366725,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13139-020-00680-5","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T11:52:56Z","timestamp":1610452376000},"page":"86-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of GATE Monte Carlo Code for Simulation and Dosimetry of New I-125 Seeds in Eye Plaque Brachytherapy"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-6219","authenticated-orcid":false,"given":"Payvand","family":"Taherparvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Fardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"680_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","volume":"110","author":"AD Singh","year":"2003","unstructured":"Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973\u20131997. Ophthalmology. 2003;110:956\u201361.","journal-title":"Ophthalmology"},{"key":"680_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clindermatol.2008.09.010","volume":"27","author":"CL Shields","year":"2009","unstructured":"Shields CL, Shields JA. Ocular melanoma: relatively rare but requiring respect. Clin Dermatol. 2009;27:122\u201333.","journal-title":"Clin Dermatol"},{"key":"680_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1442-9071.2004.00917.x","volume":"32","author":"B Damato","year":"2004","unstructured":"Damato B. Developments in the management of uveal melanoma. Clin Exp Ophthalmol. 2004;32:639\u201347.","journal-title":"Clin Exp Ophthalmol"},{"key":"680_CR4","doi-asserted-by":"crossref","unstructured":"Rajabi R, Taherparvar P. Monte Carlo dosimetry for a new 32P brachytherapy source using FLUKA code. J Contemp Brachyther. 2019;11:76\u201390.","DOI":"10.5114\/jcb.2019.83002"},{"key":"680_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0969-8043(01)00258-5","volume":"56","author":"AS Meigooni","year":"2002","unstructured":"Meigooni AS, Yoe-Sein MM, Al-Otoom AY, Sowards KT. Determination of the dosimetric characteristics of InterSource125 iodine brachytherapy source. Appl Radiat Isot. 2002;56:589\u201399.","journal-title":"Appl Radiat Isot"},{"key":"680_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1118\/1.3056463","volume":"36","author":"MJ Rivard","year":"2009","unstructured":"Rivard MJ. Monte Carlo radiation dose simulations and dosimetric comparison of the model 6711 and 9011 brachytherapy sources. Med Phys. 2009;36:486\u201391.","journal-title":"Med Phys"},{"key":"680_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.apradiso.2005.02.004","volume":"63","author":"EA Rodr\u00edguez","year":"2005","unstructured":"Rodr\u00edguez EA, Alc\u00f3n EP, Rodriguez ML, Gutt F, de Almeida E. Dosimetric parameters estimation using PENELOPE Monte-Carlo simulation code: model 6711 a 125I brachytherapy seed. Appl Radiat Isot. 2005;63:41\u20138.","journal-title":"Appl Radiat Isot"},{"key":"680_CR8","unstructured":"Meigooni A. Recent developments in brachytherapy source dosimetry. Iran J Radiat Res. 2004;2:97\u2013105."},{"key":"680_CR9","unstructured":"Zhang L, Chen H, Wang L, Liu T, Yeh J, Lu G, et al. Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy. Nanotechnology, science and applications. 2010;3:159\u201370."},{"key":"680_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ejmp.2016.07.636","volume":"32","author":"L Mostafa","year":"2016","unstructured":"Mostafa L, Rachid K, Ahmed SM. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform. Physica Medica. 2016;32:1007\u201318.","journal-title":"Physica Medica"},{"key":"680_CR11","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1118\/1.4749933","volume":"39","author":"ST Chiu-Tsao","year":"2012","unstructured":"Chiu-Tsao ST, Astrahan MA, Finger PT, Followill DS, Meigooni AS, Melhus CS, et al. Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Med Phys. 2012;39:6161\u201384.","journal-title":"Med Phys"},{"key":"680_CR12","doi-asserted-by":"crossref","unstructured":"Nag S, Quivey JM, Earle JD, Followill D, Fontanesi J, Finger PT, et al. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. International Journal of Radiation Oncology* Biology* Physics. 2003;56:544\u201355.","DOI":"10.1016\/S0360-3016(03)00006-3"},{"key":"680_CR13","first-page":"1220","volume":"29","author":"A Krintz","year":"2002","unstructured":"Krintz A, Hanson WF, Ibbott GS, Followill DS. Verification of plaque simulator dose distribution using radiochromic film. Med Phys. 2002;29:1220\u20131.","journal-title":"Med Phys"},{"key":"680_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brachy.2009.03.066","volume":"8","author":"RM Thomson","year":"2009","unstructured":"Thomson RM, Rogers DW. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models. Brachytherapy. 2009;8:130\u20131.","journal-title":"Brachytherapy."},{"key":"680_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archopht.119.7.969","volume":"119","author":"D John","year":"2001","unstructured":"John D, Earle M, Fine SL, Hawkins BS, Straatsma M, Ocular C. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. Arch Ophthalmol. 2001;119:969\u201382.","journal-title":"Arch Ophthalmol"},{"key":"680_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1118\/1.3523614","volume":"38","author":"MJ Rivard","year":"2011","unstructured":"Rivard MJ, Chiu-Tsao ST, Finger PT, Meigooni AS, Melhus CS, Mourtada F, et al. Comparison of dose calculation methods for brachytherapy of intraocular tumors. Med Phys. 2011;38:306\u201316.","journal-title":"Med Phys"},{"key":"680_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00411-018-0748-3","volume":"57","author":"A Ebrahimi-Khankook","year":"2018","unstructured":"Ebrahimi-Khankook A, Vejdani-Noghreiyan A. Dosimetric comparison between realistic ocular model and other models for COMS plaque brachytherapy with 103 Pd, 131 Cs, and 125 I radioisotopes. Radiat Environ Biophys. 2018;57:265\u201375.","journal-title":"Radiat Environ Biophys"},{"key":"680_CR18","doi-asserted-by":"crossref","unstructured":"Knutsen S, Hafslund R, Monge OR, Valen H, Muren LP, Rekstad BL, et al. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy. International Journal of Radiation Oncology* Biology* Physics. 2001;51:1159\u201366.","DOI":"10.1016\/S0360-3016(01)01768-0"},{"key":"680_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/rpd\/nci105","volume":"115","author":"H Yoriyaz","year":"2005","unstructured":"Yoriyaz H, Sanchez A, Dos Santos A. A new human eye model for ophthalmic brachytherapy dosimetry. Radiat Prot Dosim. 2005;115:316\u20139.","journal-title":"Radiat Prot Dosim"},{"key":"680_CR20","doi-asserted-by":"crossref","unstructured":"Thomson R, Taylor R, Rogers D. Monte Carlo dosimetry for 125I and 103Pd eye plaque. Med Phys.2008;35:5530\u201343.","DOI":"10.1118\/1.3002412"},{"key":"680_CR21","doi-asserted-by":"crossref","unstructured":"Thomson RM, Furutani KM, Pulido JS, Stafford SL, Rogers D. Modified COMS plaques for 125I and 103Pd iris melanoma brachytherapy. International Journal of Radiation Oncology* Biology* Physics. 2010;78:1261\u20139.","DOI":"10.1016\/j.ijrobp.2009.12.002"},{"key":"680_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.brachy.2009.07.007","volume":"9","author":"H Zhang","year":"2010","unstructured":"Zhang H, Martin D, Chiu-Tsao S-T, Meigooni A, Thomadsen BR. A comprehensive dosimetric comparison between 131Cs and 125I brachytherapy sources for COMS eye plaque implant. Brachytherapy. 2010;9:362\u201372.","journal-title":"Brachytherapy."},{"key":"680_CR23","doi-asserted-by":"publisher","DOI":"10.1118\/1.4864474","volume":"41","author":"M Lesperance","year":"2014","unstructured":"Lesperance M, Martinov M, Thomson R. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom. Med Phys. 2014;41:031706.","journal-title":"Med Phys"},{"key":"680_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1118\/1.1646040","volume":"31","author":"MJ Rivard","year":"2004","unstructured":"Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Saiful Huq M, Ibbott GS, et al. Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004;31:633\u201374.","journal-title":"Med Phys"},{"key":"680_CR25","first-page":"171","volume":"34","author":"JA Scott","year":"1993","unstructured":"Scott JA. Photon, electron, proton and neutron interaction data for body tissues ICRU report 46. International Commission on Radiation Units and Measurements. J Nucl Med. 1993;34:171.","journal-title":"J Nucl Med"},{"key":"680_CR26","unstructured":"Cantor L, Rapuano C, Cioffi G. Fundamentals and Principles of Ophthalmology. 2016-2017 American Academy of Ophthalmology-Basic and Clinical Science Course, Section 2016;2:302\u201326."},{"key":"680_CR27","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1118\/1.1500395","volume":"29","author":"AS Meigooni","year":"2002","unstructured":"Meigooni AS, Hayes JL, Zhang H, Sowards K. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE\u2122 brachytherapy source. Med Phys. 2002;29:2152\u20138.","journal-title":"Med Phys"},{"key":"680_CR28","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1118\/1.2965360","volume":"35","author":"R Taylor","year":"2008","unstructured":"Taylor R, Rogers D. An EGSnrc Monte Carlo-calculated database of TG-43 parameters. Med Phys. 2008;35:4228\u201341.","journal-title":"Med Phys"},{"key":"680_CR29","first-page":"109","volume":"10","author":"V Lohrabian","year":"2013","unstructured":"Lohrabian V, Sheibani S, Aghamiri MR, Ghozati B, Pourbeigi H, Baghani HR. Determination of dosimetric characteristics of irseed 125i brachytherapy source. Iran J Med Phys. 2013;10:109\u201317.","journal-title":"Iran J Med Phys"},{"key":"680_CR30","unstructured":"Nudat N. 2.6, national nuclear data center. Technical report, Brookhaven National Laboratory, http:\/\/www.nndc.bnl.gov\/exfor\/exfor00.htm. Last accessed on http:\/\/www-nds.iaea.org\/exfor\/exfor.htm. 2020;1:14."},{"key":"680_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1118\/1.3298008","volume":"37","author":"MJ Rivard","year":"2010","unstructured":"Rivard MJ, Granero D, Perez-Calatayud J, Ballester F. Influence of photon energy spectra from brachytherapy sources on Monte Carlo simulations of kerma and dose rates in water and air. Med Phys. 2010;37:869\u201376.","journal-title":"Med Phys"},{"key":"680_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13246-017-0607-6","volume":"41","author":"P Taherparvar","year":"2018","unstructured":"Taherparvar P, Sadremomtaz A. Development of GATE Monte Carlo simulation for a CsI pixelated gamma camera dedicated to high resolution animal SPECT. Australas Phys Eng Sci Med. 2018;41:31\u20139.","journal-title":"Australas Phys Eng Sci Med"},{"key":"680_CR33","doi-asserted-by":"crossref","unstructured":"Thiam C, Breton V, Donnarieix D, Habib B, Maigne L. Validation of a dose deposited by low-energy photons using GATE\/GEANT4. Phys Med Biol. 2008;53:3039\u201355.","DOI":"10.1088\/0031-9155\/53\/11\/019"},{"key":"680_CR34","doi-asserted-by":"publisher","DOI":"10.1118\/1.4860135","volume":"41","author":"P Aryal","year":"2014","unstructured":"Aryal P, Molloy JA, Rivard MJ. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data. Med Phys. 2014;41:021702.","journal-title":"Med Phys"},{"key":"680_CR35","unstructured":"Baghani H, Lohrabian V, Aghamiri MR, Robatjazi M. Monte Carlo determination of dosimetric parameters of a new 125I brachytherapy source according to AAPM TG-43 (U1) protocol. Arch Iran Med. 2016;19:186\u201391."},{"key":"680_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1120\/jacmp.v3i2.2576","volume":"3","author":"TD Solberg","year":"2002","unstructured":"Solberg TD, DeMarco JJ, Hugo G, Wallace RE. Dosimetric parameters of three new solid core I-125 brachytherapy sources. J Appl Clin Med Phys. 2002;3:119\u201334.","journal-title":"J Appl Clin Med Phys"}],"container-title":["Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-020-00680-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13139-020-00680-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-020-00680-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T03:42:38Z","timestamp":1618803758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13139-020-00680-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1007\/s13139-020-00680-5","relation":{},"ISSN":["1869-3474","1869-3482"],"issn-type":[{"value":"1869-3474","type":"print"},{"value":"1869-3482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Payvand Taherparvar and Zeinab Fardi declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The institutional review board of our institute approved this retrospective study, and the requirement to obtain informed consent was waived","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}